title: [Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)].
abstract: In a clinical multicenter observational study including 584 women attended by 99 participating gynaecologists the quality of life changes after 3 month use of an oral contraceptive preparation containing 30 mcg ethinylestradiol (EE) and 3 mg drospirenone was evaluated through the use of a self developed questionnaire using 20 items with a 5 scale answer scheme. We found a mean positive change of life quality of 7.3%. Significant changes were observed regarding subjective experiences of weight, skin, hair, cycle, attractivity, libido and mental wellbeing.
authors.affiliation: Abteilung für gynäkologische Sozialmedizin und Psychosomatik der Universitätsfrauenklinik Basel.
authors.forename: J
authors.initials: J
authors.lastname: Bitzer
authors.forename: S
authors.initials: S
authors.lastname: Tschudin
authors.forename: J
authors.initials: J
authors.lastname: Meier-Burgoa
authors.forename: U
authors.initials: U
authors.lastname: Armbruster
authors.forename: A
authors.initials: A
authors.lastname: Schwendke
mesh_terms: D000328:Adult; D000736:Androstenes / Q000008:administration & dosage; D001835:Body Weight; D003276:Contraceptives, Oral / Q000008:administration & dosage; D003627:Data Interpretation, Statistical; D004997:Ethinyl Estradiol / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007989:Libido; D008598:Menstruation; D045167:Progesterone Congeners / Q000008:administration & dosage; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D000736:Androstenes; D003276:Contraceptives, Oral; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; C035144:drospirenone